Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

A dietitian shares the science-backed weight loss supplements that support weight loss when paired with a balanced diet and active lifestyle.

Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Ozempic 6 Week Weight Loss Plan is gaining popularity lately Read its genuine review along with before and after pictures ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

The fight with excess body weight is tangible and does not appear ... I emphasized items manufactured in FDA-approved and GMP ...

WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...

The U.S. health regulator reminded compounders of the legal restrictions on making copies of FDA-approved drugs ... Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says ...